Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Sodium Salicylate: Evidence, Mechanism and Scope
2026-10-16
APExBIO describes sodium salicylate as a small-molecule NF-κB inhibitor for inflammation, immunology, oxidative-stress and related signaling research. The available evidence is limited to product information: it documents chemical identity, selected physical specifications and a proposed mechanism, but provides no identity-matched study, biological outcome data or independent validation of pathway selectivity.
-
Deoxycholic Acid Sodium Salt: Evidence Boundaries
2026-10-16
The APExBIO listing identifies Deoxycholic acid sodium salt (SKU C6885), but the available product entry provides no description, mechanism, assay, performance data, or identity-matched research citation. This editorial therefore distinguishes chemical identity from demonstrated biological or analytical function and defines what cannot be concluded from the listing alone.
-
Deoxycholic Acid Sodium Salt: Evidence Boundaries
2026-10-15
APExBIO lists C6885 as deoxycholic acid sodium salt, but the available product information contains no description, mechanism, assay context, or identity-matched research paper. The scientifically supportable interpretation is therefore limited to catalog identity and evidence provenance; biological activity, measurement behavior, performance, and applicability remain undocumented here.
-
Genistein: Product Identity and Evidence Boundaries
2026-10-15
The APExBIO catalog description identifies Genistein as the isoflavonoid 5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one and attributes protein tyrosine kinase, growth-factor signaling, cellular, and animal-model findings to summarized prior work. The reported IC50 and ED50 values are assay-specific, while the absence of an identity-matched primary paper limits conclusions about selectivity, mechanism, reproducibility, and translational relevance.
-
BODIPY 581/591 C11: Interpreting the Readout
2026-10-14
The APExBIO product description identifies BODIPY 581/591 C11 as a cell-permeable, ratiometric fluorescent probe intended to report membrane-associated lipid oxidation through a red-to-green spectral shift. The documented information supports a conceptual measurement overview, but no identity-matched research paper, quantitative outcome, or independent performance comparison is available here.
-
SNORA38B in NSCLC: Promise and Evidence Gaps
2026-10-14
A 2022 preclinical study links elevated SNORA38B with poorer outcomes in non-small cell lung cancer and reports effects on tumor growth, immune-cell composition, and response to immune checkpoint blockade. The findings are mechanistically coherent but remain limited by model dependence, observational human evidence, and the absence of clinical validation or broad comparative testing.
-
Bufalin and CENPA in HCC: Evidence and Limits
2026-10-13
An early pre-proof study links Bufalin with reduced CENPA expression, glycolysis-associated signaling, and migration in hepatocellular carcinoma models. The findings are mechanistically suggestive but remain preliminary because the evidence is largely cellular, computational, and based on limited xenograft immunohistochemistry rather than clinical outcomes.
-
Netrin-1 and Adipose Remodeling: Evidence Boundaries
2026-10-13
A mouse study links adipose-derived Netrin-1 to impaired adipogenesis and metabolic dysfunction, while its relevance to human obesity and diabetes remains unestablished.
-
A Reporter-Gene Test of Rabbit Pharming Yield
2026-10-12
Song et al. report a targeted rabbit line in which a native milk-protein regulatory element drives tdTomato expression, with substantially higher milk-associated recombinant protein levels in homozygous animals than the historical yields summarized in the paper. The result is promising as a proof of concept, but it does not yet establish comparable performance for therapeutic proteins or resolve how much of the effect derives from promoter choice, targeted integration, copy number, or genetic background.
-
Evidence Gaps in TNBC Axis Comparisons
2026-10-12
A source-grounded interpretation of a 2025 TNBC study and the evidentiary limits of linking its molecular findings to Protein A/G Magnetic Beads or related affinity platforms.
-
Netrin-1 and Adipose Remodeling: Evidence and Limits
2026-10-11
A mouse study links adipose-derived Netrin-1 with impaired adipogenesis and metabolic dysfunction, but the evidence remains preclinical and tissue- and model-specific.
-
Protein A/G Magnetic Beads in TNBC Research
2026-10-10
Protein A/G Magnetic Beads offer a useful analytical framework for studying antibody-defined complexes in triple-negative breast cancer. This article connects recombinant Protein A and Protein G beads with the IGF2BP3–FZD1/7 mechanism while emphasizing evidence strength, assay interpretation, and translational limitations.
-
DiD: Reading Cell Trajectories in Inflammation
2026-10-09
DiD (DiDC 18 (5)) provides a red membrane signal for interpreting cell location, persistence, and tissue organization in complex inflammation models. This article explains how to use membrane labeling as spatial evidence without confusing fluorescence with direct proof of mitochondrial repair or therapeutic mechanism.
-
Influenza Hemagglutinin (HA) Peptide: Evidence Lens
2026-10-09
The Influenza Hemagglutinin (HA) Peptide is more than a compact affinity handle: it can help researchers interpret what HA-tagged interaction data actually demonstrate. This article connects its competitive antibody-binding logic with the RAB31 exosome study while defining evidence boundaries, controls, and applicability limits.
-
5-hme-dCTP in Plant Epigenetic Research
2026-10-08
5-hme-dCTP is a research-grade modified nucleotide associated with studies of 5-hydroxymethylcytosine, an uncommon DNA modification whose role in plants remains unresolved. This overview examines the rice drought-response study by Yan and colleagues, compares the evidence generated by different detection approaches, and explains why the findings support context-dependent associations rather than definitive causal mechanisms.